CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells

Development of the hybridoma technology by Köhler and Milstein (1975) has revolutionized the immunological field by enabling routine use of monoclonal antibodies (mAbs) in research and development efforts, resulting in their successful application in the clinic today. While recombinant good manufact...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Camille Le Gall, Felix Fennemann, Johan van der Schoot, Ferenc Scheeren, Martijn Verdoes
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Bio-protocol LLC 2023-02-01
Цуврал:	Bio-Protocol
Онлайн хандалт:	https://bio-protocol.org/en/bpdetail?id=4613&type=0
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!